Background: RNA splicing, a fundamental step in gene expression, is aimed at intron removal and ordering of exons to form the protein's reading frame.
Objective: This review is focused on the role of RNA splicing in cancer biology; the splicing abnormalities that lead to tumor progression emerge as targets for therapeutic intervention.
Methods: We discuss the role of aberrant mRNA splicing in carcinogenesis and drug response.
Results and conclusion: Pharmacological modulation of RNA splicing sets the stage for treatment approaches in situations where mRNA splicing is a clinically meaningful mechanism of the disease.
Keywords: Cancer; RNA splicing; molecular drug targets; protein kinase inhibitors.; therapy.
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.